PneumoNIX Medical was selected to present to Johns Hopkins Hospital, Maryland Department of Commerce and Technology Development Corporation of Maryland about their technology and its ability to increase access to lung cancer screening. The successful large-animal data which was acquired with grant funding has gathered interest from physicians and public health officials about its ability to reduce costs and complications during the lung cancer screening process. Additionally, the results have fast-tracked them for further grant funding.
top of page
bottom of page